Patents by Inventor Wolfgang Koechling

Wolfgang Koechling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THE USE OF GNRH ANTAGONIST PEPTIDE IN THE TREATEMENT OF SEX HORMONE-DEPENDENT DISEASES
    Publication number: 20110053846
    Abstract: A method for treatment of benign prostate hyperplasia, prostate cancer, estrogen-dependent breast cancer, endometrial cancer, ovarian cancer, endometriosis and precocious puberty, or for use for contraceptive purposes or in an in vitro fertilization programme, or for treatment of sex offenders is provided. The method comprises the administration by subcutaneous or intramuscular injection of a therapeutically effective amount of an injectable pharmaceutical composition comprising a solution of a GnRH antagonist peptide according to general formula 1 or a pharmaceutically acceptable salt thereof in a concentration of 0.3-120 mg/ml. Also a pharmaceutical composition and a pharmaceutical kit of parts are provided.
    Type: Application
    Filed: October 8, 2010
    Publication date: March 3, 2011
    Inventors: Martin Lück, Wolfgang Koechling, Pierre Broqua
  • Gonadotropin releasing hormone antagonists in gel-forming concentration
    Publication number: 20040038903
    Abstract: A method for treatment of benign prostate hyperplasia, prostate cancer, estrogen-dependent breast cancer, endometrial cancer, ovarian cancer, endometriosis and precocious puberty, or for use for contraceptive purposes or in an in vitro fertilization programme, or for treatment of sex offenders is provided. The method comprises the administration by subcutaneous or intramuscular injection of a therapeutically effective amount of an injectable pharmaceutical composition comprising a solution of a GnRH antagonist peptide according to general formula 1 or a pharmaceutically acceptable salt thereof in a concentration of 0.3-120 mg/ml. Also a pharmaceutical composition and a pharmaceutical kit of parts are provided.
    Type: Application
    Filed: August 20, 2003
    Publication date: February 26, 2004
    Inventors: Martin Luck, Wolfgang Koechling, Pierre Broqua